Attach to Form 990 or Form 990-EZ.
See separate instructions.| (i) Name of supported organization |
(ii) EIN |
(iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) |
(iv) Is the organization in col. (i) listed in your governing document? |
(v) Did you notify the organization in col. (i) of your support? |
(vi) Is the organization in col. (i) organized in the U.S.? |
(vii) Amount of support? |
|||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | ||||
| Total | |||||||||
| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3.. | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public Support. Subtract line 5 from line 4. | ||||||
| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. (Explain in Part IV.) Do not include gain or loss from the sale of capital assets.. | ||||||
| 11 | Total support (Add lines 7 through 10). | ||||||






| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 10,019,866 | 2,928,249 | 9,732,535 | 9,749,125 | 8,931,139 | 41,360,914 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | 52,328,773 | 8,421,317 | 55,457,162 | 54,860,215 | 58,117,275 | 229,184,742 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513.. | 291,953 | 89,689 | 257,198 | 155,397 | 235,462 | 1,029,699 |
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | 62,640,592 | 11,439,255 | 65,446,895 | 64,764,737 | 67,283,876 | 271,575,355 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | 14,233,783 | 3,589,400 | 11,825,034 | 11,459,125 | 10,056,139 | 51,163,481 |
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | |||||
| c | Add lines 7a and 7b.. | 14,233,783 | 3,589,400 | 11,825,034 | 11,459,125 | 10,056,139 | 51,163,481 |
| 8 | Public Support (Subtract line 7c from line 6.) | 220,411,874 | |||||
| Calendar year (or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 62,640,592 | 11,439,255 | 65,446,895 | 64,764,737 | 67,283,876 | 271,575,355 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 2,585,211 | 700,422 | 2,234,994 | 1,248,387 | 848,971 | 7,617,985 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 3,328,558 | 1,418,830 | 1,237,990 | 1,445,377 | 2,794,100 | 10,224,855 |
| c | Add lines 10a and 10b. | 5,913,769 | 2,119,252 | 3,472,984 | 2,693,764 | 3,643,071 | 17,842,840 |
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) | 1,434,494 | 661,354 | 2,444,918 | 2,303,656 | 2,884,051 | 9,728,473 |
| 13 | Total support (Add lines 9, 10c, 11 and 12.). | 69,988,855 | 14,219,861 | 71,364,797 | 69,762,157 | 73,810,998 | 299,146,668 |




| Facts And Circumstances Test |
|---|
| Explanation |
|---|
| SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: CHANGE IN FISCAL YEAR REPORTING: ASCO'S 2007 REPORTED FIGURES REPRESENT THE FINANCIAL TRANSACTIONS FROM ASCO'S SHORT-YEAR PERIOD OF SEPTEMBER 1 - DECEMBER 31, 2007. THIS SHORT-YEAR REPRESENTS A TRANSITIONAL REPORTING PERIOD FOR ASCO FROM A FISCAL YEAR END OF AUGUST 31ST TO A CALENDAR FISCAL YEAR. |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.| Identifier | Return Reference | Explanation |
|---|---|---|
| NEW PROGRAM SERVICES | FORM 990, PART III, LINE 2 | ASCO'S QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) IS AN ONCOLOGIST-LED, PRACTICE-BASED QUALITY IMPROVEMENT PROGRAM. NEW IN 2010 IS ASCO'S QOPI CERTIFICATION PROGRAM WHICH BUILDS UPON THE SUCCESS OF QOPI. QOPI CERTIFICATION DEMONSTRATES A COMMITMENT TO EXCELLENCE AND ONGOING QUALITY IMPROVEMENT IN THE HEMATOLOGY-ONCOLOGY OUTPATIENT PRACTICE. THE GOALS OF THE QOPI CERTIFICATION PROGRAM ARE TO: -- PROMOTE HIGH QUALITY CANCER CARE AS DEFINED BY THE CLINICIAN EXPERTS. -- PROVIDE A TRUSTED SOLUTION TO SATISFY EXTERNAL DEMAND FOR QUALITY ACTIVITIES. -- REDUCE REDUNDANT PROGRAMS OR ADMINISTRATIVE BURDENS FOR ONCOLOGY PRACTICES, INCLUDING HEALTH PLAN PROGRAMS. THE QOPI CERTIFICATION PROGRAM IS CARRIED OUT BY A SPECIAL-PURPOSE LIMITED LIABILITY COMPANY LIMITED LIABILITY CORPORATION (LLC), THE INSTITUTE OF CLINICAL EXCELLENCE, THE INSTITUTE OF CLINICAL EXCELLENCE, LLC INCLUDES THE TRADE NAME QOPI CERTIFICATION PROGRAM. THE SOLE MEMBER OF THIS LLC IS ASCO AND THE ACTING MANAGER IS ASCO'S CHIEF EXECUTIVE OFFICER. |
| FORM 990, PART VI, SECTION A, LINE 1 | AS OF DECEMBER 31, 2010, THE BOARD OF DIRECTORS OF ASCO INCLUDED 18 MEMBERS WITH VOTING RIGHTS: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND 14 DIRECTORS. ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS ARE ELECTED BY VOTING MEMBERS OF ASCO AND HAVE THE SAME VOTING RIGHTS. THE CHIEF EXECUTIVE OFFICER (CEO) IS AN EX-OFFICIO, NON-VOTING MEMBER OF THE BOARD OF DIRECTORS. DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. DURING THE REPORTING YEAR, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE WERE: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND THOSE DIRECTORS SERVING THEIR FINAL YEAR OF THEIR TERM. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS. | |
| FORM 990, PART VI, SECTION A, LINE 6 | ASCO MEMBERS ARE ELECTED BY THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. THE CATEGORIES OF MEMBERSHIP AND SPECIFIED RIGHTS ARE AS FOLLOWS: 1. ACTIVE MEMBERS. 1.A. ACTIVE MEMBERS ARE EXPERIENCED LICENSED PHYSICIANS OF ANY NATION WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. IN EXCEPTIONAL CASES, OTHER PHYSICIANS WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS TO THE FIELD ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANKS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. 1.B. RIGHTS OF ACTIVE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS, SERVE ON ALL COMMITTEES OF ASCO, AND VOTE AND HOLD OFFICE IN ASCO. 2. INTERNATIONAL CORRESPONDING MEMBERS. 2.A. INTERNATIONAL CORRESPONDING MEMBERS ARE EXPERIENCED PHYSICIANS WHO ARE ELIGIBLE TO BE ACTIVE MEMBERS, BUT WHO RESIDE IN A DEVELOPING NATION OR A NATION WITH A LOW PER-CAPITA INCOME, AS DEFINED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. 2.B. RIGHTS OF INTERNATIONAL CORRESPONDING MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. INTERNATIONAL CORRESPONDING MEMBERS MAY NOT SERVE ON COMMITTEES OF ASCO, AND MAY NOT VOTE OR HOLD OFFICE IN ASCO. 3. ACTIVE-ALLIED MEMBERS. 3.A. ACTIVE-ALLIED MEMBERS ARE OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANK WHO ARE NOT ELIGIBLE TO BE AN ACTIVE MEMBER AND WHO HAVE A PREDOMINANT INTEREST IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. 3.B. RIGHTS OF ACTIVE-ALLIED MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND TO SERVE ON ALL COMMITTEES OF ASCO. ACTIVE-ALLIED MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 4. AFFILIATE MEMBERS. 4.A. AFFILIATE MEMBERS ARE ONCOLOGY NURSES, PHYSICIAN ASSISTANTS, AND OTHER HEALTH SPECIALISTS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO THE CARE AND TREATMENT OF PATIENTS WITH NEOPLASTIC DISEASES. MEMBERSHIP IS LIMITED TO THOSE PARAMEDICAL PERSONNEL WHO FUNCTION AS INTEGRAL MEMBERS OF A TEAM OF ONCOLOGISTS RESPONSIBLE FOR THE CARE OF SUCH PATIENTS OR WHO ENGAGE IN THE CONDUCT OF CLINICAL TRIALS. ELECTION TO MEMBERSHIP IS BASED ON EXPERIENCE IN AND CONTRIBUTIONS TO THE FIELD OF ONCOLOGY. ADDITIONALLY, AFFILIATE MEMBER STATUS INCLUDES INDIVIDUALS WHO HOLD LEADERSHIP POSITIONS OR HAVE TAKEN A DISTINGUISHED LEADERSHIP ROLE IN A NATIONALLY OR INTERNATIONALLY RECOGNIZED NOT-FOR-PROFIT, TAX-EXEMPT ORGANIZATION DEDICATED TO CANCER PATIENT ADVOCACY OR SURVIVORSHIP. 4.B. RIGHTS OF AFFILIATE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND SERVE ON ALL COMMITTEES OF ASCO. AFFILIATE MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 5. EMERITUS MEMBERS. 5.A. EMERITUS MEMBERS ARE ACTIVE, ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING AND AFFILIATE MEMBERS WHO HAVE REQUESTED EMERITUS STATUS AT AGE 65, UPON RETIREMENT OR EARLIER IF PERMANENTLY DISABLED. 5.B. RIGHTS OF EMERITUS MEMBERS INCLUDE BEING EXEMPT FROM MEMBERSHIP DUES. EMERITUS MEMBERS WHO AT THE TIME OF THE REQUEST WERE ACTIVE MEMBERS RETAIN ALL RIGHTS AND PRIVILEGES OF ACTIVE MEMBER STATUS, EXCEPT THE HOLDING OF OFFICE. EMERITUS MEMBERS WHO WERE PREVIOUSLY ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING OR AFFILIATE MEMBERS RETAIN ALL THE RIGHTS AND PRIVILEGES OF ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING OR AFFILIATE MEMBER STATUS RESPECTIVELY. 6. HONORARY MEMBERS. 6.A. HONORARY MEMBERS ARE INDIVIDUALS WHO HAVE MADE AN OUTSTANDING CONTRIBUTION TO CLINICAL ONCOLOGY WHO ARE DESIGNATED AS AN HONORARY MEMBER BY THE BOARD OF DIRECTORS. 6.B. RIGHTS OF HONORARY MEMBERS INCLUDE HAVING ALL PRIVILEGES OF ACTIVE MEMBERS, EXCEPT THEY MAY NOT HOLD OFFICE AND ARE EXEMPT FROM PAYING MEMBERSHIP DUES. 7. ASSOCIATE MEMBERS. 7.A. ASSOCIATE MEMBERS ARE HEALTH PROFESSIONALS HAVING AN MD, DO, PHD, PHARMD, OR OTHER DOCTORAL DEGREE, WHO ARE PARTICIPATING IN A SUBSPECIALTY TRAINING PROGRAM IN ONCOLOGY OR ANOTHER FIELD THAT WOULD LEAD TO ELIGIBILITY FOR ACTIVE OR ACTIVE-ALLIED MEMBERSHIP. 7.B. RIGHTS OF ASSOCIATE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. ASSOCIATE MEMBERS MAY NOT HOLD OFFICE OR VOTE, EXCEPT THAT THEY MAY SERVE AS VOTING MEMBERS OF COMMITTEES OF ASCO. | |
| FORM 990, PART VI, SECTION A, LINE 7A | VOTING MEMBERS OF ASCO ELECT ALL 18 VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS: THE PRESIDENT, PRESIDENT-ELECT, PAST-PRESIDENT, TREASURER, AND 14 DIRECTORS. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: ACTIVE MEMBERS; EMERITUS MEMBERS WHO WERE ACTIVE MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS; AND HONORARY MEMBERS. | |
| FORM 990, PART VI, SECTION B, LINE 11 | AN ELECTRONIC COPY OF THE ASCO FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS AND WAS DISCUSSED AT A MEETING OF THE BOARD BEFORE IT WAS FILED. THE ASCO FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE CHIEF EXECUTIVE OFFICER, AND THE VICE PRESIDENT AND GENERAL COUNSEL PRIOR TO FILING. | |
| FORM 990, PART VI, SECTION B, LINE 12C | ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E., A ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. | |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE CEO OF ASCO'S NON-PROFIT, 501(C) (3) TAX-EXEMPT AFFILIATE, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION); THE PRESIDENT OF INSTITUTE OF CLINICAL EXCELLENCE, LLC (D/B/A QOPI CERTIFICATION PROGRAM); AND THE PRESIDENT OF ASCO LEASING, LLC. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CEO WAS REASONABLE. THE REVIEW, RECOMMENDATION, AND DETERMINATION OF THE CEO'S COMPENSATION BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. COMPENSATION OF CERTAIN OFFICERS AND KEY EMPLOYEES OF ASCO VICE PRESIDENT/ GENERAL COUNSEL: THE COMPENSATION OF THE VICE PRESIDENT/GENERAL COUNSEL (VP/GC) WAS CONSIDERED AND APPROVED BY THE COMPENSATION COMMITTEE, AFTER CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE VP/GC WAS REASONABLE. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE VP/GC AND ASCO ADDRESSES COMPENSATION OF THE VP/GC. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE VP/GC BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. CHIEF FINANCIAL OFFICER (CFO): THE COMPENSATION OF THE CHIEF FINANCIAL OFFICER (CFO) WAS CONSIDERED AND APPROVED BY THE COMPENSATION COMMITTEE, AFTER CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CFO WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE CFO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. EXECUTIVE DIRECTOR OF THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION): THE EXECUTIVE DIRECTOR OF CCF IS AN EMPLOYEE OF ASCO. THE COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF AFTER RECEIVING THE RECOMMENDATIONS OF THE CEO AND THE ADVICE OF INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY: THE COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY AFTER RECEIVING THE RECOMMENDATIONS OF THE CEO AND THE ADVICE OF INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY BASED ON THE ABOVE DESCRIBED PROCESS WERE UNDERTAKEN IN 2010. | |
| FORM 990, PART VI, SECTION C, LINE 19 | ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE, WAS PUBLISHED IN THE JANUARY 20, 2006 EDITION OF JOURNAL OF CLINICAL ONCOLOGY (THE EDITION IS AVAILABLE TO THE PUBLIC FOR FREE), AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S ANNUAL REPORT IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. | |
| FORM 990, PART VI, SECTION A, LINE 7B: | NO DECISIONS OF THE GOVERNING BODY ARE SUBJECT TO APPROVAL BY MEMBERS, STOCKHOLDERS, OR OTHER PERSONS. HOWEVER, THE BYLAWS MAY ONLY BE AMENDED AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED BY VOTING MEMBERS OF ASCO. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: ACTIVE MEMBERS; EMERITUS MEMBERS WHO WERE ACTIVE MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS; AND HONORARY MEMBERS. | |
| FORM 990, PART VI, SECTION B, LINE 10B: | ALTHOUGH ASCO HAS STATE AND REGIONAL AFFILIATES THROUGH ITS STATE AND REGIONAL AFFILIATE PROGRAM, ASCO DOES NOT HAVE THE LEGAL AUTHORITY TO EXERCISE SUPERVISION AND CONTROL OVER THEM AND EACH AFFILIATE IS A SEPARATELY INCORPORATED LEGAL ENTITY THAT IS RESPONSIBLE FOR ITS OWN FISCAL MANAGEMENT. AFFILIATES MAY NOT ACT ON BEHALF OF ASCO AND ARE PROHIBITED FROM ANY ACTION THAT MIGHT IMPLY AN AGENCY RELATIONSHIP. AFFILIATES MAY NOT BIND ASCO TO ANY CONTRACT WITH A THIRD PARTY. ASCO'S STATE AND REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ASSIST STATE AND REGIONAL SOCIETIES IN ADDRESSING THE PRACTICAL ISSUES FACING PHYSICIANS WHO CARE FOR PEOPLE WITH CANCER AND TO FACILITATE AND ENCOURAGE INVOLVEMENT IN ASCO'S PUBLIC POLICY INITIATIVES. EACH AFFILIATE HAS A VOTING REPRESENTATIVE ON THE ASCO CLINICAL PRACTICE COMMITTEE (CPC), WHICH IS INTENDED TO ADDRESS THE INTERESTS OF PRACTICING ONCOLOGISTS, WITH A PARTICULAR FOCUS ON REIMBURSEMENT FOR, ACCESS TO, AND QUALITY OF MEDICAL ONCOLOGY SERVICES. THROUGH PARTICIPATION IN THE CPC, AFFILIATES HAVE A ROLE IN THE DEVELOPMENT OF PUBLIC POLICY POSITIONS AT THE NATIONAL LEVEL AND ASCO RECEIVES INPUT REGARDING STATE AND REGIONAL ISSUES AFFECTING ONCOLOGY. STATE AND REGIONAL SOCIETIES INTERESTED IN BEING AFFILIATES MUST SUBMIT AN APPLICATION TO ASCO THAT, AMONG OTHER THINGS, REQUIRES THEM TO DEMONSTRATE THAT THEY ARE VALIDLY INCORPORATED UNDER STATE LAW, HAVE IN PLACE GOVERNANCE PRACTICES AND PROCEDURES (BYLAWS, OFFICERS, DIRECTORS, ELECTIONS, MEETINGS, AND RESPONSIBLE FISCAL MANAGEMENT) AND HAVE PHYSICIAN MEMBERSHIP REQUIREMENTS THAT ARE CONSISTENT WITH ASCO'S STANDARDS. ASCO PROVIDES STATE AFFILIATES WITH A VARIETY OF ASSISTANCE, INCLUDING ASCO POLICY ANALYSES, ACCESS TO ASCO STAFF ON MATTERS OF INTEREST TO STATE AFFILIATES, AND ASSISTANCE WITH MEDIA AND OUTREACH. | |
| CHANGES IN NET ASSETS OR FUND BALANCES: | FORM 990, PART XI, LINE 5: | NET UNREALIZED GAINS ON INVESTMENTS: 4,589,913. |
| FORM 990. PART XII, LINE 2C: | THERE HAS BEEN NO CHANGE IN THE PROCESS FROM THE PREVIOUS YEAR. ASCO HAS AN AUDIT COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT REVIEW. |
| Software ID: | |
| Software Version: |